BCM
CNST

Beryl Capital Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Beryl Capital Management’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-130,861
Closed -$4.42M – 287
2021
Q2 		$4.42M Buy
+130,861
New +$3.33M 0.39% 79

Beryl Capital Management's CNST Position: Q3 2021 in Review

Beryl Capital Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 130,861 shares — an estimated $4.42M sold.

Beryl Capital Management first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $4.42M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Beryl Capital Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Beryl Capital Management sold 130,861 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $4.42M.
  • Beryl Capital Management first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
  • Beryl Capital Management's Constellation Pharmaceuticals, Inc. position peaked at $4.42M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Beryl Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.